TradeTech Europe 2025

13 - 15 May, 2025

Palais des Congrès de Paris

Dimitri Mongeot

Senior Cross Assets Derivatives Trader AXA Investment Managers

Dimitri is a senior Cross-Assets Derivatives Trader part of the Axa IM derivatives Team since 2019. Before joining Axa, Dimitri was Vice-President, trading Interest rates derivatives on the sell side at NatWest markets Singapore market making Fixed Income bonds, Swaps and options. Previously at Société Générale, Dimitri oversaw USD-AUD-NZD-CAD swaps and US Treasuries in Hong Kong, London and New York. Dimitri started his career as a fixed Income Trader at ING Financial Markets NY in 2008 after graduating from Columbia University Master’s program of Financial Engineering and Ecole Centrale Paris as Valedictorian.

Day 1 | 14th May

2:15 PM Market Structure Panel: Navigating market structure complexities: What are the latest market structure and product developments that will help drive interoperability and improve ease of equity derivatives trading?

The US has seen huge growth in derivatives volumes and retail participation in recent years, whilst the European market has remained flat. This is attributed to the lack of retail investor education, and a fragmented market structure with siloed liquidity and clearing models, creating a more complex and costly trading environment. The speakers will look to unpack solutions and ways to improve the current siloed model to lower the barrier to entry and to encourage greater participation, as well as product trends and the migration from OTC to listed.

  • How do the EU and US market models differ, and can Europe achieve more competition whilst removing venue and clearing silos?
  • What effort is being made to address the siloed liquidity and clearing model to bring more interoperability to the market?
  • Examining the product complexities in Europe, and how products have different tax treatments
  • How are liquidity dynamics shifting in OTC vs listed derivatives, and what are the benefits and disadvantaged to both?
  • Are we seeing a greater push from OTC to listed due to regulation and balance sheet limitations, and what new innovative listed products are being developed as a result?

Check out the incredible speaker line-up to see who will be joining Dimitri.

Download The Latest Agenda